Journal
ORPHANET JOURNAL OF RARE DISEASES
Volume 11, Issue -, Pages -Publisher
BMC
DOI: 10.1186/s13023-016-0441-z
Keywords
Fabry disease; Lyso-Gb3; Variant of unknown significance; Late-onset; GLA mutation; Stroke; Genotype
Funding
- Deutsche Forschungsgemeinschaft
- Open Access Publication Fund of the University of Muenster
- Genzyme GmbH, Germany
Ask authors/readers for more resources
Background: Fabry disease (FD) is an X-linked multisystemic disorder with a heterogeneous phenotype. Especially atypical or late-onset type 2 phenotypes present a therapeutical dilemma. Methods: To determine the clinical impact of the alpha-Galactosidase A (GLA) p.A143T/c.427G>A variation, we retrospectively analyzed 25 p.A143T patients in comparison to 58 FD patients with other missense mutations. Results: p.A143T patients suffering from stroke/transient ischemic attacks had slightly decreased residual GLA activities, and/or increased lyso-Gb3 levels, suspecting FD. However, most male p.A143T patients presented with significant residual GLA activity (similar to 50 % of reference), which was associated with normal lyso-Gb3 levels. Additionally, p.A143T patients showed less severe FD-typical symptoms and absent FD-typical renal and cardiac involvement in comparison to FD patients with other missense mutations. Two tested female p.A143T patients with stroke/TIA did not show skewed X chromosome inactivation. No accumulation of neurologic events in family members of p.A143T patients with stroke/transient ischemic attacks was observed. Conclusions: We conclude that GLA p.A143T seems to be most likely a neutral variant or a possible modifier instead of a disease-causing mutation. Therefore, we suggest that p.A143T patients with stroke/transient ischemic attacks of unknown etiology should be further evaluated, since the diagnosis of FD is not probable and subsequent ERT or chaperone treatment should not be an unreflected option.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available